3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

被引：23

作者：

So, Anthony D. ^{[1
]}

Ruiz-Esparza, Quentin ^{[1
]}

Gupta, Neha ^{[1
]}

Cars, Otto ^{[2
]}

机构：

[1] Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA

[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2012年 / 344卷

关键词：

D O I：

10.1136/bmj.e1782

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：4

共 28 条

[1] [Anonymous], THER DRUGS CENTR NER
[2] [Anonymous], POLICIES INCENTIVES
[3] [Anonymous], BACTERIAL CHALLENGE
[4] NIH Molecular Libraries Initiative
Austin, CP
Brady, LS
Insel, TR
Collins, FS
[J]. SCIENCE, 2004, 306 (5699) : 1138 - 1139
[5] BCC Research, 2010, CARD THER DRUGS TECH
[6] BCC Research, 2010, INF DIS TREATM GLOB
[7] The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance
Bergstrom, Richard
[J]. DRUG RESISTANCE UPDATES, 2011, 14 (02) : 77 - 78
[8] Hit and lead generation:: Beyond high-throughput screening
Bleicher, KH
Böhm, HJ
Müller, K
Alanine, AI
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) : 369 - 378
[9] Reengineering Translational Science: The Time Is Right
Collins, Francis S.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (90)
[10] DiMasi JA, 2004, DRUG INF J, V38, P211, DOI 10.1177/009286150403800301